Summary
Athera Biotechnologies AB (Athera) is a biopharmaceutical company that develops targeted anti inflammatory biological candidate drugs and companion diagnostics for cardiovascular disease. The company's product includes PC-mAb, which is a fully human monoclonal antibody that neutralizes a key driver of vascular inflammation, phosphorylcholine. It has developed a proprietary companion diagnostic CVDefine kit to identify patients with low anti-PC levels in need of receiving PC-mAb therapy.
Read More
- List of Tables
- Athera Biotechnologies AB, Pharmaceuticals & Healthcare, Key Facts 1
- Athera Biotechnologies AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
- Athera Biotechnologies AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
- Athera Biotechnologies AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
- Athera Biotechnologies AB, Deals By Therapy Area, 2011 to YTD 2017 8
- Athera Biotechnologies AB, Pharmaceuticals & Healthcare, Deals Sum
Read More
- Table of Contents
- Table of Contents 2
- List of Tables 3
- List of Figures 4
- Athera Biotechnologies AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
- Athera Biotechnologies AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
- Athera Biotechnologies AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
- Athera Biotechnologies AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
- Athera Biotechnologies AB, Pharmaceuticals &
Read More